Dan Berger
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Synthesis and pharmacology of benzodiazepine derivatives
Papers in
-
- Cancer therapeutics and mechanisms 3
- Melanoma and MAPK Pathways 3
- Protein Kinase Regulation and GTPase Signaling 3
- Protein Tyrosine Phosphatases 2
-
- Quinazolinone synthesis and applications 3
- Synthesis and biological activity 3
- Synthesis and Biological Evaluation 2
- Co-authors
- Ronald Breslow (1 shared paper)Minu Dutia (6 shared papers)Dennis Powell (6 shared papers)H.H. Fiebig (3 shared papers)Hans R. Hendriks (3 shared papers)Gilberto Schwartsmann (2 shared papers)William Hallett (1 shared paper)Herbert M. Pinedo (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)European Journal of Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of the American Chemical Society (1 paper)Tetrahedron (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Dan Berger
12 papers receiving 332 citations
Peers
Comparison fields: 5 of 66
- Toxicology 52
- Organic Chemistry 186
- Oncology 100
- Molecular Biology 191
- Cancer Research 31
Countries citing papers authored by Dan Berger
This map shows the geographic impact of Dan Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Berger more than expected).
Fields of papers citing papers by Dan Berger
This network shows the impact of papers produced by Dan Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Berger. The network helps show where Dan Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 89 | |
| 2 | 1999 | 60 | |
| 3 | 1990 | 57 | |
| 4 | 1998 | 28 | |
| 5 | 1992 | 25 | |
| 6 | 2003 | 25 | |
| 7 | 2002 | 18 | |
| 8 | 2009 | 16 | |
| 9 | 2004 | 13 | |
| 10 | 2008 | 11 | |
| 11 | 2002 | 8 | |
| 12 | 2003 | 4 |
About Dan Berger
Dan Berger is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Pharmacology and Oncology, having authored 12 papers that have together received 354 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (4 papers), Quinazolinone synthesis and applications (3 papers), Cancer therapeutics and mechanisms (3 papers), Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Synthesis and biological activity (3 papers), Protein Tyrosine Phosphatases (2 papers) and Synthesis and Biological Evaluation (2 papers). The work is most often cited by research in Toxicology (52 citations), Organic Chemistry (186 citations), Oncology (100 citations), Molecular Biology (191 citations) and Cancer Research (31 citations). Dan Berger has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Ronald Breslow, Minu Dutia, Dennis Powell, H.H. Fiebig, Hans R. Hendriks, Gilberto Schwartsmann, William Hallett, Herbert M. Pinedo, Rolf Paul and Lee M. Greenberger. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Cancer, Molecular Cancer Therapeutics, Journal of the American Chemical Society and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.